Publication: Interim results from a large multinational extension trial (guardian™2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A
Loading...
Date
2016
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
